You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

FLUDEOXYGLUCOSE F-18 - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic drug sources for fludeoxyglucose f-18 and what is the scope of freedom to operate?

Fludeoxyglucose f-18 is the generic ingredient in one branded drug marketed by Downstate Clincl, 3d Imaging Drug, Biomedcl Res Fdn, Brigham Womens, Cardinal Health 414, Childrens Hosp Mi, Decatur, Essential Isotopes, Feinstein, Hot Shots Nm Llc, Isologic Innovative, Jubilant Draximage, Kettering Medctr, Kreitchman Pet Ctr, Ma General Hosp, Mcprf, Mem Sloan-kettering, Methodist Hosp Res, Midwest Medcl, Mips Crf, Ncm Usa Bronx Llc, Northland, Nukemed, Petnet, Pharmalogic, Pharmalogic Hldgs, Precision Nuclear, Queen Hamamatsu Pet, Sofie, Trustees Univ Pa, Ucla Biomedical, Ucsf Rodiopharm, Uihc Pet Imaging, Univ Michigan, Univ Southern Ca, Univ Tx Md Anderson, Univ Tx Sw Medctr, Univ Utah Cyclotron, Weill Medcl Coll, Wisconsin, and Wusm Cyclotron, and is included in forty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for fludeoxyglucose f-18. Twenty-six suppliers are listed for this compound.

Summary for FLUDEOXYGLUCOSE F-18

US Patents:	0
Tradenames:	1
Applicants:	41
NDAs:	43
Drug Master File Entries:	3
Finished Product Suppliers / Packagers:	26
Raw Ingredient (Bulk) Api Vendors:	20
Clinical Trials:	183
Patent Applications:	1,672
What excipients (inactive ingredients) are in FLUDEOXYGLUCOSE F-18?	FLUDEOXYGLUCOSE F-18 excipients list
DailyMed Link:	FLUDEOXYGLUCOSE F-18 at DailyMed

Recent Clinical Trials for FLUDEOXYGLUCOSE F-18

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Robert Flavell, MD, PhD	Phase 1
Michael Topf	Phase 1
Xencor, Inc.	Phase 1

See all FLUDEOXYGLUCOSE F-18 clinical trials

Pharmacology for FLUDEOXYGLUCOSE F-18

Drug Class	Radioactive Diagnostic Agent
Mechanism of Action	Radiopharmaceutical Activity

Anatomical Therapeutic Chemical (ATC) Classes for FLUDEOXYGLUCOSE F-18

US Patents and Regulatory Information for FLUDEOXYGLUCOSE F-18

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ucsf Rodiopharm	FLUDEOXYGLUCOSE F18	fludeoxyglucose f-18	INJECTABLE;INTRAVENOUS	203902-001	May 9, 2014	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Mips Crf	FLUDEOXYGLUCOSE F18	fludeoxyglucose f-18	INJECTABLE;INTRAVENOUS	204472-001	Sep 11, 2015	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Univ Tx Md Anderson	FLUDEOXYGLUCOSE F18	fludeoxyglucose f-18	INJECTABLE;INTRAVENOUS	203246-001	Jan 13, 2014		RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Feinstein	FLUDEOXYGLUCOSE F18	fludeoxyglucose f-18	INJECTABLE;INTRAVENOUS	021870-002	Nov 21, 2008	AP	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.